primary sclerosing cholangitis

Influential Pliant Persuades Investors, Propelling Stock Skyward with Promising Liver Disease Efficacy Data

Pliant Therapeutics has captured the attention of investors with compelling early clinical findings regarding its lead drug candidate’s potential to ...